Fluidization characterization in the ConSigma 25 dryer via process data - A method of advanced quality assurance in continuous manufacturing.

Continuous wet granulation Fluid bed drying Fluidization characterization Online process monitoring

Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
25 Sep 2021
Historique:
received: 07 04 2021
revised: 22 07 2021
accepted: 21 08 2021
pubmed: 30 8 2021
medline: 23 9 2021
entrez: 29 8 2021
Statut: ppublish

Résumé

Wet granulation lines in pharmaceutical manufacturing facilities typically comprise a dryer that removes the excess moisture content after wet granulation. In this study, a semi-continuous dryer installed in the ConsiGma 25 wet granulation line was investigated. The goal was to highlight specific characteristics of this type of dryer, utilizing the available process data and the corresponding data obtained via material characterization. This paper addresses typical effects and issues associated with the dryer's setup and operation (e.g., unexpected cell temperature profiles, the effects of air flow and temperature on the granule properties, variations in the granule moisture between the dryer cells). Since in many situations the liquid-to-solid ratio is based on the properties of granules after the granulation step, the selection of inlet air flow rate and the inlet air temperature of the dryer as well as the overall line throughput (affecting the cell fill level in the dryer) are of particular interest from a practical point of view. This paper discusses these issues and provides suggestions on how to address them when setting up the process. A novel approach for characterizing the fluidization inside the dryer by means of quantifying the "smoothness" of the temperature profile is proposed. The paper should be viewed as a hands-on guideline, which highlights possible pitfalls during the process setup and offers solutions.

Identifiants

pubmed: 34455056
pii: S0378-5173(21)00847-4
doi: 10.1016/j.ijpharm.2021.121041
pii:
doi:

Substances chimiques

Powders 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121041

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Jakob Rehrl (J)

Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13/2, 8010 Graz, Austria. Electronic address: jakob.rehrl@rcpe.at.

Theresa Hörmann-Kincses (T)

Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13/2, 8010 Graz, Austria. Electronic address: theresa.hoermann@rcpe.at.

Rok Sibanc (R)

Bayer AG, Engineering & Technology, 51368 Leverkusen, Germany. Electronic address: rok.sibanc@bayer.com.

Wen-Kai Hsiao (WK)

Research Center Pharmaceutical Engineering GmbH, Inffeldgasse 13/2, 8010 Graz, Austria. Electronic address: wen-kai.hsiao@rcpe.at.

Meik Franke (M)

Bayer AG, Engineering & Technology, 51368 Leverkusen, Germany; Faculty of Science and Technology (TNW), University of Twente, Drienerlolaan 5, 7522 NB Enschede, the Netherlands(1). Electronic address: meik.franke@bayer.com.

Johannes Khinast (J)

Institute for Process and Particle Engineering, Graz University of Technology, Inffeldgasse 13/3, 8010 Graz, Austria. Electronic address: khinast@tugraz.at.

Articles similaires

Animals Dietary Fiber Dextran Sulfate Mice Disease Models, Animal
Calcium Carbonate Sand Powders Construction Materials Materials Testing
Animals Rumen Methane Fermentation Cannabis

Classifications MeSH